Leukocytes of 22 individuals were incubated with a suboptimal concentration of eosinophil granule major basic protein and the amount of histamine release was determined. Cells from 20 of the 22 donors had a histamine release of ≥ 15%. The use of selected donors on repeated occasions revealed significant variability in individual donor responsiveness. The findings support a role for major basic protein activation of human basophils in allergic reactions. The presence in eosinophils of enzymes that degrade basophil and mast cell mediators led to the hypothesis that eosinophils dampen allergic reactions [1]. Recent evidence suggests, however, that eosinophils may actually contribute to the pathogenesis. Major basic protein (MBP), a 9,300-dalton basic poly-peptide localized in the crystalloid core of the eosinophil granule [2], is toxic for mammalian cells including respiratory epithelium [3], is present in elevated concentrations in fluids of patients with eosinophilia [2, 3], and is deposited at sites of bronchial epithelial damage [4] and in urticarial lesions [5]. A pathogenic role for eosinophils and MBP was strengthened by the finding that MBP also stimulated noncytolytic histamine release from human basophils and rat mast cells [6]. To assess differences in individual donor sensitivity to basophil activation by MBP, we measured the amount of histamine release stimulated by a single concentration of MBP from cells of 22 individuals. Leukocytes isolated by dextran sedimentation or basophil-containing mononuclear cells isolated by Ficoll-Hypaque density centrifugation were incubated with 3.4×10-6M purified human MBP for 45 min at 37 °C. The resultant histamine release values for the 22 donors ranged from 4-54% ( fig. 1, left panel) . Basophils from the majority of the individuals tested released 15-30% of their histamine content, while basophils from a smaller percentage of donors released ^40% of their histamine content. Cells of two individuals yielded < 5% histamine release. To assess the reproducibility of the response of individual donors, cells of 5 individuals were tested on repeated occasions with the same concentration of MBP ( fig. 1, right panel) . Cells of 3 donors (■, O, A) yielded fairly consistent histamine release values but cells of 2 of the 5 donors (·, Δ) exhibited considerable variability.
The presence in eosinophils of enzymes that degrade basophil and mast cell mediators led to the hypothesis that eosinophils dampen allergic reactions [1] . Recent evidence suggests, however, that eosinophils may actually contribute to the pathogenesis. Major basic protein (MBP), a 9,300-dalton basic poly-peptide localized in the crystalloid core of the eosinophil granule [2] , is toxic for mammalian cells including respiratory epithelium [3] , is present in elevated concentrations in fluids of patients with eosinophilia [2, 3] , and is deposited at sites of bronchial epithelial damage [4] and in urticarial lesions [5] . A pathogenic role for eosinophils and MBP was strengthened by the finding that MBP also stimulated noncytolytic histamine release from human basophils and rat mast cells [6] . To assess differences in individual donor sensitivity to basophil activation by MBP, we measured the amount of histamine release stimulated by a single concentration of MBP from cells of 22 individuals. Leukocytes isolated by dextran sedimentation or basophil-containing mononuclear cells isolated by Ficoll-Hypaque density centrifugation were incubated with 3.4×10-6M purified human MBP for 45 min at 37 °C. 
